Showing results (1-10 of 217) with videos related to
Sort By:
Pageof 22
Presse Medicale (Paris, France : 1983)|April 1, 2014
Thrombopoietic agents: there is still much to learnJames B Bussel, Madhavi LakkarajaBritish Journal of Haematology|July 5, 2025
Precision transplant and cell therapies for non-malignant disorders-The path forwardMadhavi Lakkaraja, K Scott BakerBlood|July 26, 2015
Suppression of in vitro megakaryopoiesis by maternal sera containing anti-HPA-1a antibodiesZhi-Jian Liu, James B Bussel, Madhavi Lakkaraja, et al.American Journal of Obstetrics and Gynecology|May 2, 2016
Omission of fetal sampling in treatment of subsequent pregnancies in fetal-neonatal alloimmune thrombocytopeniaMadhavi Lakkaraja, Richard L Berkowitz, Cheryl A Vinograd, et al.Transfusion|September 10, 2016
Blood group A mothers are more likely to develop anemia during antenatal intravenous immunoglobulin treatment of fetal and neonatal alloimmune thrombocytopeniaMadhavi Lakkaraja, Jenny C Jin, Karen C Manotas, et al.Journal of the National Medical Association|June 11, 2016
Caregiver's Health Locus of Control and Medication Adherence in Sickle Cell DiseaseKusum Viswanathan, Neeraja Swaminathan, Ramaswamy Viswanathan, et al.British Journal of Haematology|November 21, 2022
Why should intramuscular anti-D be different from intravenous anti-D?James B BusselBest Practice & Research. Clinical Haematology|December 3, 2014
The new thrombopoietic agenda: impact on leukemias and MDSJames B BusselAmerican Journal of Perinatology|January 3, 2004
Fetal and neonatal cytopenias: what have we learned?James B BusselHematology/Oncology Clinics of North America|November 26, 2009
Traditional and new approaches to the management of immune thrombocytopenia: issues of when and who to treatJames B BusselPageof 22